Mechanism of islet amyloid polypeptide fibrillation at lipid interfaces studied by infrared reflection absorption spectroscopy

Biophysical Journal

Volumn 93, Issue 9, 2007, Pages 3132-3141

  Lopes, D H J ^a   Meister, A ^b   Gohlke, A ^a   Hauser, A ^b   Blume, A ^b   Winter, Roland ^a  

^a TU DORTMUND UNIVERSITY   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN;

ABSORPTION SPECTROSCOPY; ARTICLE; ATOMIC FORCE MICROSCOPY; BETA SHEET; HORMONE BINDING; HORMONE DETERMINATION; HORMONE STRUCTURE; HUMAN; INFRARED SPECTROSCOPY; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; PROTEIN LIPID INTERACTION; REFLECTOMETRY;

EID: 36049013172     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1529/biophysj.107.110635     Document Type: Article

References (67)

1. Scheibel, T. 2005. Protein fibers as performance proteins: new technologies and applications. Curr. Opin. Biotechnol. 16:427-433.
2. Kelly, J. W. 1998. The alternative conformations of amyloidogenic proteins and their multi-step assembly pathway. Curr. Opin. Struct. Biol. 8:101-106.
3. Dobson, C. M. 2001. The structural basis of protein folding and its links with human disease. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356:133-145.
4. Goedert, M. 2001. Alpha-synuclein and neurodegenerative diseases. Nat. Rev. Neurosci. 2:492-501.
5. De Felice, F. G., and S. T. Ferreira. 2002. β-amyloid production, aggregation, and clearance as targets for therapy in Alzheimer's disease. Cell. Mol. Neurobiol. 22:545-563.
6. Guo, J.-P., T. Arai, J. Miklossy, and P. L. McGeer. 2006. Aβ and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 103:1953-1958.
7. Inouye, H., D. Sharma, W. J. Goux, and D. A. Kirschner. 2006. Structure of core domain of fibril-forming PHF/tau fragments. Biophys. J. 90:1774-1789.
8. Thompson, M. J., S. A. Sievers, J. Karanicolas, M. I. Ivanova, D. Baker, and D. Eisenberg. 2006. The 3D profile method for identifying fibril-forming segments of proteins. Proc. Natl. Acad. Sci. USA. 103:4074-4078.
9. Rojas Quijano, F. A., D. Morrow, B. M. Wise, F. L. Brancia, and W. J. Goux. 2006. Prediction of nucleating sequences from amyloidogenic propensities of tau-related peptides. Biochemistry. 45:4638-4652.
10. Makin, O. S., E. Atkins, P. Sirkorski, J. Johansson, and L. C. Serpell. 2005. Molecular basis for amyloid fibril formation and stability. Proc. Natl. Acad. Sci. USA. 102:315-320.
11. Tycko, R. 2004. Progress towards a molecular-level structural understanding of amyloid fibrils. Curr. Opin. Struct. Biol. 14:96-103.
12. Cordeiro, Y., J. Kraineva, M. C. Suarez, A. G. Tempesta, J. W. Kelly, J. L. Silva, R. Winter, and D. Foguel. 2006. Fourier transform infrared spectroscopy provides a fingerprint for the tetramer and for the aggregates of transthyretin. Biophys. J. 91:957-967.
13. Grudzielanek, S., V. Smirnovas, and R. Winter. 2006. Solvation-assisted pressure tuning of insulin fibrillation: from novel aggregation pathways to biotechnological applications. J. Mol. Biol. 356:497-509.
14. Cooper, G. J. S., A. J. Day, A. C. Willis, A. N. Roberts, K. B. M. Reid, and B. Leighton. 1989. Amylin and the amylin gene: structure, function and relationship to islet amyloid and to diabetes mellitus. Biochim. Biophys. Acta. 1014:247-258.
15. Cooper, G. J. S., A. C. Willis, and B. Leighton. 1989. Amylin hormone. Nature. 340:272.
16. Ohsawa, H., A. Kanatsuka, T. Yamaguchi, H. Makino, and S. Yoshida. 1989. Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion fromisolated rat pancreatic islets. Biochem. Biophys. Res. Commun. 160:961-967.
17. Fehmann, H. C., V. Weber, R. Goke, B. Goke, R. Eissele, and R. Arnold. 1990. Islet amyloid polypeptide (IAPP;amylin) influences the endocrine but not the exocrine rat pancreas. Biochem. Biophys. Res. Commun. 167:1102-1108.
18. Johnson, K. H., T. D. O'Brien, C. Betsholtz, and P. Westermark. 1992. Islet amyloid polypeptide: mechanisms of amyloidogenesis in the pancreatic islets and potential roles in diabetes mellitus. Lab. Invest. 66:522-535.
19. Engel, M. F. M., H. Yigittop, R. C. Elgersma, D. T. S. Rijkers, R. M. J. Liskamp, B. de Kruiff, J. W. M. Höppener, and J. A. Killian. 2006. Islet amyloid polypeptide inserts into phospholipid monolayers as monomer. J. Mol. Biol. 356:783-789.
20. Quist, A., I. Doudevski, H. Lin, R. Azimova, D. Ng, B. Frangione, B. Kagan, J. Ghiso, and R. Lal. 2005. Amyloid ion channels: a common structural link for protein-misfolding disease. Proc. Natl. Acad. Sci. USA. 102:10427-10432.
21. Green, J. D., C. Goldsbury, J. Kistler, G. J. S. Cooper, and U. Aebi. 2004. Human amylin oligomer growth and fibril elongation define two distinct phases in amyloid formation. J. Biol. Chem. 279:12206-12212.
22. Kayed, R., J. Bernhagen, N. Greenfield, K. Sweimeh, H. Brunner, W. Voelter, and A. Kapurniotu. 1999. Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro. J. Mol. Biol. 287:781-796.
23. Sparr, E., M. F. M. Engel, D. V. Sakharov, M. Sprong, J. Jacobs, B. de Kruijff, J. W. M. Hoppener, and J. A. Killian. 2004. Islet amyloid polypeptide-induced membrane leakage involves uptake of lipids by forming amyloid fibers. FEBS Lett. 577:117-120.
24. Porat, Y., S. Kolusheva, R. Jelinek, and E. Gazit. 2003. The human islet amyloid polypeptide forms transient membrane-active prefibrillar assemblies. Biochemistry. 42:10971-10977.
25. Harroun, T. A., J. P. Bradshaw, and R. H. Ashley. 2001. Inhibitors can arrest the membrane activity of human islet amyloid polypeptide independently of amyloid formation. FEBS Lett. 507:200-204.
26. Janson, J., P. C. Butler, and W. Soeller. 1998. High islet amyloid polypeptide secretion results in transient hyperglycemia without beta-cell death. Diabetes. 47(Suppl. 1):A30.
27. Mirzabekov, T. A., M. C. Lin, and B. L. Kagan. 1996. Pore formation by the cytotoxic islet amyloid peptide amylin. J. Biol. Chem. 271:1988-1992.
28. Knight, J. D., J. A. Hebda, and A. D. Miranker. 2006. Conserved and cooperative assembly of membrane-bound α-helical states of islet amyloid polypeptide. Biochemistry. 45:9496-9508.
29. Jayasinghe, S. A., and R. Langen. 2005. Lipid membranes modulate the structure of islet amyloid polyp. Biochemistry. 44:12113-12119.
30. Westermark, P., and E. Wilander. 1978. The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus. Diabetologia. 15:417-421.
31. Maloy, A. L., D. S. Longnecker, and E. R. Greenberg. 1981. The relation of islet amyloid to the clinical type of diabetes. Hum. Pathol. 12:917-922.
32. Hayden, M. R. 2002. Pancreatic islet amyloid in type 2 diabetes mellitus: a clinical and historical review. Mo. Med. 99:495-498.
33. Green, J. D., L. Kreplak, C. Goldsbury, X. Li Blatter, M. Stolz, G. Cooper, A. Seelig, J. Kistler, and U. Aebi. 2004. Atomic force microscopy reveals defects within mica supported lipid bilayers induced by the amyloidogenic human amylin peptide. J. Mol. Biol. 342:877-887.
34. Balali-Mood, K., R. H. Ashley, T. Hauss, and J. P. Bradshaw. 2005. Neutron diffraction reveals sequence-specific membrane insertion of pre-fibrillar islet amyloid polypeptide and inhibition by rifampicin. FEBS Lett. 579:1143-1148.
35. Knight, J. D., and A. D. Miranker. 2004. Phospholipid catalysis of diabetic amyloid assembly. J. Mol. Biol. 341:1175-1187.
36. Demuro, A., E. Mina, R. Kayed, S. C. Milton, I. Parker, and C. G. Glabe. 2005. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J. Biol. Chem. 280:17294-17300.
37. Kayed, R., E. Head, J. L. Thompson, T. M. McIntire, S. C. Milton, C. W. Cotman, and C. G. Glabe. 2003. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science. 300:486-489.
38. Kayed, R., Y. Sokolov, B. Edmonds, T. M. McIntire, S. C. Milton, J. E. Hall, and C. G. Glabe. 2004. Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J. Biol. Chem. 279:46363-46366.
39. Anguiano, M., R. J. Nowak, and P. T. Lansbury Jr. 2002. Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes. Biochemistry. 41:11338-11343.
40. Tschop, M., and M. L. Heiman. 2001. Rodent obesity models: an overview. Exp. Clin. Endocrinol. Diabetes. 109:307-319.
41. Hoppener, J. W., C. Oosterwijk, M. G. Nieuwenhuis, G. Posthuma, J. H. Thijssen, T. M. Vroom, B. Ahren, and C. J. Lips. 1999. Extensive islet amyloid formation is induced by development of type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model. Diabetologia. 42:427-434.
42. Butler, A. E., J. Jang, T. Gurlo, M. D. Carty, W. C. Soeller, and P. C. Butler. 2004. Diabetes due to a progressive defect in beta-cell mass in rats transgenic for human islet amyloid polypeptide (HIP Rat): a new model for type 2 diabetes. Diabetes. 53:1509-1516.
43. Flach, C. R., J. W. Brauner, J. W. Taylor, R. C. Baldwin, and R. Mendelsohn. 1994. External reflection FTIR of peptide monolayer films in situ at the air/water interface: experimental design, spectra-structure correlations, and effects of hydrogen-deuterium exchange. Biophys. J. 67:402-410.
44. Lad, M. D., F. Birembaut, R. A. Frazier, and R. J. Green. 2005. Protein-lipid interactions at the air/water interface. Phys. Chem. Chem. Phys. 7:3478-3485.
45. Wang, L., P. Cai, H.-J. Galla, H. He, C. R. Flach, and R. Mendelsohn. 2005. Monolayer-multilayer transitions in a lung surfactant model: IR reflection-absorption spectroscopy and atomic force microscopy. Eur. Biophys. J. 34:243-254.
46. Xu, Z., J. W. Brauner, C. R. Flach, and R. Mendelsohn. 2004. Orientation of peptides in aqueous monolayer films. Infrared reflection-absorption spectroscopy studies of a synthetic amphipathic β-sheet. Langmuir. 20:3730-3733.
47. Kerth, A., A. Erbe, M. Dathe, and A. Blume. 2004. Infrared reflection absorption spectroscopy of amphipathic model peptides at the air/water interface. Biophys. J. 86:3750-3758.
48. Maltseva, E., A. Kerth, A. Blume, H. Möhwald, and G. Brezesinski. 2005. Adsorption of amyloid beta (1-40) peptide at phospholipid monolayers. ChemBioChem. 6:1817-1824.
49. Meister, A., C. Nicolini, H. Waldmann, J. Kuhlmann, A. Kerth, R. Winter, and A. Blume. 2006. Insertion of lipidated Ras proteins into lipid monolayers studied by infrared reflection absorption spectroscopy (IRRAS). Biophys. J. 91:1388-1401.
50. Demel, R. A., W. S. Geurts van Kessel, R. F. Zwaal, B. Roelofsen, and L. L. van Deenen. 1975. Relation between various phospholipase actions on human red cell membranes and the interfacial phospholipid pressure in monolayers. Biochim. Biophys. Acta. 406:97-107.
51. Higham, C. E., E. T. A. S. Jaikaran, P. E. Fraser, M. Gross, and A. Clark. 2000. Preparation of synthetic human islet amyloid polypeptide (IAPP) in a stable conformation to enable study of conversion to amyloid-like fibrils. FEBS Lett. 470:55-60.
52. Jaikaran, E. T., and A. Clark. 2001. Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology. Biochim. Biophys. Acta. 1537:179-203.
53. Kajava, A. V., U. Aebi, and A. C. Steven. 2005. The parallel superpleated beta-structure as a model for amyloid fibrils of human amylin. J. Mol. Biol. 348:247-252.
54. Lorenzo, A., B. Razzaboni, G. C. Weir, and B. A. Yankner. 1994. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature. 368:756-760.
55. Deleage, G., and B. Roux. 1987. An algorithm for protein secondary structure prediction based on class prediction. Protein Eng. 1:289-294.
56. Levin, T. M., and J. Garnier. 1988. Improvements in a secondary structure prediction method based on a search for local sequence homologies and its use as a model building tool. Biochim. Biochim. Acta. 955:283-295.
57. Geourjon, C., and G. Deleage. 1994. SOPM: a self-optimized method for protein secondary structure prediction. Protein Eng. 7:157-164.
58. Ma, Z., G. T. Westermark, S. Sakagashira, T. Sanke, A. Gustavsson, H. Sakamoto, U. Engstrom, K. Nanjo, and P. Westermark. 2001. Enhanced in vitro production of amyloid-like fibrils from mutant (S20G) islet amyloid polypeptide. Amyloid. 8:242-249.
59. Jansen, R., W. Dzwolak, and R. Winter. 2005. Amyloidogenic self-assembly of insulin aggregates probed by high resolution atomic force microscopy. Biophys. J. 88:1344-1353.
60. Jaikaran, E. T., C. E. Higham, L. C. Serpell, J. Zurdo, M. Gross, A. Clark, and P. E. Fraser. 2001. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis. J. Mol. Biol. 308:515-525.
61. Williamson, J. A., and A. D. Miranker. 2007. Direct detection of transient alpha-helical states in islet amyloid polypeptide. Protein Sci. 16:1-8.
62. Shao, H., S.-C. Jao, K. Ma, and M. G. Zagorski. 1999. Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's disease. J. Mol. Biol. 285:755-773.
63. Kirkitadze, M. D., M. M. Condron, and D. B. Teplow. 2001. Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis. J. Mol. Biol. 312:1103-1119.
64. Kessler, J. C., J. C. Rochet, and P. T. Lansbury Jr. 2003. The N-terminal repeat domain of alpha-synuclein inhibits beta-sheet and amyloid fibril formation. Biochemistry. 42:672-678.
65. Chiti, F., and C. M. Dobson. 2006. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 75:333-366.
66. Kajava, A. V., E. Aebi, and A. C. Steven. 2005. The parallel superpleated beta-structure as a model for amyloid fibrils of human amylin. J. Mol. Biol. 348:247-252.
67. Goldsbury, C., J. Kistler, U. Aebi, T. Arvinte, and G. J. S. Cooper. 1999. Watching amyloid fibrils grow by time-lapse atomic force microscopy. J. Mol. Biol. 285:33-39.